drugset

drugset / Trial / NCT07339345

Prospective Single-Arm Clinical Trial of GO Regimen for HLH.

NCT07339345 ↗

Phase 2/3 Recruiting 28 enrolled Beijing Friendship Hospital

NaSingle-groupOpen-labelTreatment

Summary

This study aims to investigate the efficacy and safety of Golidocitinib(GO) monotherapy in the treatment of hemophagocytic lymphohistiocytosis.

Timeline

Start: 2025-06-27
Primary completion: 2026-06-27
Completion: 2027-06-27

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Golidocitinib	Small molecule	150 mg	—

Indications